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Abstract
BACKGROUND 
Reverse bevel (RB) needle is widely used for endoscopic ultrasound fine needle 
biopsy (EUS-FNB). A 3-plane symmetrical needle with Franseen geometry (FG) 
has recently become available.
AIM 
To compare the clinical efficacy of FG to that of RB needle.
METHODS 
A retrospective cohort study of all adult patients who underwent EUS-FNB for 
solid and mixed lesions either with 22G RB needle or 22G FG needle between 
January 2016 and February 2019 was undertaken. All cytology slides were 
reviewed by an independent gastrointestinal cytopathologist blinded to the 
needle used and the initial cytology report. The primary and secondary outcomes 
were to assess the sample adequacy using Euro-cytology criteria and the number 
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of cell clusters, respectively.
RESULTS 
Two hundred and twenty six procedures were included in the study. RB needle 
was used in 128 procedures and FG needle in 98 procedures. The baseline 
characteristics of both groups were comparable. On multivariable analysis, FG 
needle (P = 0.02) and location of the lesion (P < 0.01) were independently 
associated with adequate tissue. Further, the use of FG needle (P = 0.04) and the 
size of the lesion (P = 0.02) were independently associated with acquisition of 
increased number of cell clusters.
CONCLUSION 
FG needle is superior to RB needle in acquiring adequate tissue and attaining 
higher number of cell clusters for solid and mixed lesions.
Key Words: Endoscopic ultrasound; Fine needle aspiration; Fine needle biopsy; Reverse 
bevel; Franseen geometry; Tissue acquisition
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Core Tip: Despite retrospective, it is the first paper to try to compare the performance of 
reverse bevel fine needle biopsy (FNB) needle with Franseen geometry FNB needle in 
term of tissue acquisition and number of cell groups in specimen. Slides reviewed by an 
independent expert gastrointestinal cytopathologist blinded to needle type used and 
original cytology reports to minimize bias.
Citation: Chow CW, Haider SA, Ragunath K, Aithal GP, James MW, Ortiz-Fernandez-Sordo J, 
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endoscopic ultrasound needle. World J Gastrointest Endosc 2020; 12(9): 266-275
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INTRODUCTION
Endoscopic ultrasound (EUS) is widely used as a diagnostic tool to obtain tissue from 
abdominal and thoracic lesions via the gastrointestinal (GI) tract. The procedure is 
minimally-invasive and well-tolerated by patients[1,2]. A number of factors have been 
shown to influence successful tissue acquisition including lesion position[3,4], lesion 
size[5-8], needle type[9-12], needle size[13-16], number of passes[17-21], technical skills[22-25] and 
the presence of rapid on-site cytological evaluation (ROSE)[1,26-28].
Fine needle biopsy (FNB) needles have been in use since 2003[29]. European Society 
of Gastroenterology recommends using 22G or 25G needles for the sampling of solid 
masses and lymph nodes[1]. Reverse bevel (RB) needle (ProCore®, Cook Medical) is the 
most widely studied FNB needle[13,15,17,30-41]. Evidence for needles such as Franseen 
geometry (FG) needle (Acquire™, Boston Scientific), fork-tip needle (Shark Core; 
Medtronic) and antegrade core trap needle (ProCore® 20G, Cook Medical) are 
emerging, but limited. Two meta-analysis comparing RB needle with fine needle 
aspiration (FNA) needle reported no significant difference in sample adequacy, 
diagnostic accuracy or core tissue acquisition rate; however, RB needle was able to 
establish the diagnosis with less number of passes[30,31].
On the other hand, in recent studies, FG needle has been shown to have a better 
tissue acquisition, better tissue architecture, higher diagnostic accuracy compared to 
standard FNA needle[42-44]. Studies have also shown better performance of FG needle 
against other newer needles such as Echo-Tip Ultra needle (Cook Medical, Indiana)[45] 
and antegrade core trap needle (ProCore® 20G, Cook Medical)[46]. However, the 
literature on direct comparison of FG needle with the commonly used RB needle is 
lacking. In this retrospective study, we compare the real-life efficacy of 22G FG needle 
to that of 22G RB needle.
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MATERIALS AND METHODS
Patient selection and data collection
A single centre retrospective cohort study was undertaken at Nottingham University 
Hospitals NHS Trust, a high-volume regional referral centre. All adult (age ≥ 18 years) 
patients who underwent EUS-FNB between January 2016 and February 2019, using 
either 22G RB needle or 22G FG needle were included in this study. Those who 
underwent EUS-FNB with other types of needles and 25G FG were excluded due to 
small numbers. Demographic characteristics, details of EUS procedure and 
cytopathology reports were extracted from the electronic patient record and 
endoscopy database.
The study was approved by Nottingham University Hospitals National Health 
Service Trust review board (ID number 19-551C).
Endoscopic ultrasound and tissue acquisition
All procedures were carried out under conscious sedation or deep sedation with 
general anaesthesia using either Olympus GF-UCT240 or Olympus GF-UCT260 
curvilinear-array echo-endoscope. Fanning technique with dry suction or slow pull 
through was used for tissue acquisition. The specimens were collected in either 
Cytorich preservative fluid or formalin, and then sent to pathology department for 
processing and reporting. ROSE of specimens was not performed in any of the 
procedures as it was not available. For the purposes of this study, location of the lesion 
was categorised into four groups–gut wall lesions, pancreatic lesions, extramural 
lesions and lymph nodes. The nature of lesion was categorised into solid or mixed 
(solid with cystic component).
Blinded review of cytology slides
All cytology slides were reviewed by an independent expert GI cytopathologist 
(Haider SA), who was blinded to the type of needle used and previous cytology 
report, and reported according to the Euro-cytology criteria[46] (C1: Inadequate and 
non-diagnostic; C2: Benign; C3: Atypical cells found which favour benign; C4: 
Suspicious of malignancy; C5: Malignant). For the purpose of assessing tissue 
adequacy, C1 category was defined as inadequate tissue acquisition; C2, C3, C4, and 
C5 categories were defined as adequate tissue acquisition. The number of cell clusters 
per slide was also reported by the cytopathologist. A cell cluster was defined as group 
of cells with more than 2 cells; individual scattered cells were not counted as cell 
clusters. Cell cluster data was divided into greater than or equal to 50 cell clusters and 
less than 50 cell clusters for analysis.
Outcomes
The primary outcome was to identify factors that impact tissue adequacy (Euro-
cytology C1 vs C2-C5) and the secondary outcome was to identify factors that impact 
the number of cell clusters in the specimen slides.
Statistical analysis
Continuous variables were presented as mean and standard deviation. Categorical 
variables were presented as number and percentage. All statistical analyses were 
performed using SPSS for Windows v26 (IBM Corp, Armonk, NY, United States). 
Fisher's exact test was used for categorical parameters with 2 × 2 contingency table and 
Pearson’s chi-square test was used for categorical parameters with contingency table 
dimensions that exceeded 2 × 2. Unpaired student’s t test or 1-way ANOVA test was 
used to study the relationship between categorical parameters with continuous 
parametric parameters. A P value of < 0.05 was considered significant. Variables with 
a P value ≤ 0.10 were included in the multivariable logistic regression analysis to 
identify independent factors. Cohen's kappa test was used to measure the inter-rater 
agreement between the interpretation of the independent GI cytopathologist and the 
original cytology reports.
RESULTS
Demographics and clinical characteristics
A total of 226 patient episodes were included in this study. Of which, 128 procedures 
were sampled using 22G RB needle and 98 were sampled using 22G FG needle. The 
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demographic characteristics of RB and FG needle groups were comparable and 
summarised in Table 1. There were no differences in age (P = 0.29), gender distribution 
(P = 0.42), location of the lesion (P = 0.55), nature of the lesion (P = 0.34), size of the 
lesion (P = 0.67), number of needle passes (P = 0.77), presence of trainee (P = 0.12) and 
the use of Sonovue contrast (P = 0.17) between the two groups.
Assessment by a GI cytopathologist
The kappa score of agreement between the independent GI cytopathologist review and 
the original cytology results was 0.671 (95%CI: 0.595-0.747; P < 0.01).
Primary outcome
The overall sample adequacy of the entire study cohort was 87.6%. The tissue 
adequacy in the FG needle group was 93% and RB needle group was 83%.
On univariable analysis, use of FG needle (P = 0.03) and the location of lesion (P < 
0.01) were associated with adequate tissue acquisition (Table 2). Age (P = 0.88), gender 
(P = 1.00), presence of trainee (P = 1.00), lesion size (P = 0.11), nature of lesion (P = 
0.62), number of passes (P = 0.61) and Sonovue contrast (P = 0.50) were not associated 
with adequate tissue acquisition (Table 2). On binary logistic regression analysis, the 
use of FG needle (OR 3.01; 95%CI: 1.15-7.86, P = 0.02) and the location of the lesion 
with pancreas (OR 9.42; 95%CI: 3.51-25.33, P < 0.01) were independently associated 
with adequate tissue acquisition (Table 2).
Secondary outcome
On univariable analysis, only the lesion size (P = 0.02) was associated with acquisition 
of ≥ 50 cell clusters; use of FG needle (P = 0.07) and solid lesions (P = 0.09) approached, 
but did not reach statistical significance (Table 3). Age (P = 0.67), gender (P = 0.13), 
location of the lesion (P = 0.39), presence of trainee (P = 0.25), number of passes (P = 
0.65) and Sonovue contrast (P = 1.00) were not associated with acquisition of ≥ 50 cell 
clusters (Table 3). Lesion size, type of needle and nature of the lesion were included in 
the binary logistic regression analysis. Use of FG needle (OR 1.79; 95%CI: 1.02-3.12, P = 
0.04) and larger lesion size (OR 1.02; 95%CI: 1.00-1.03, P = 0.02) were independently 
associated with acquisition of ≥ 50 cell clusters (Table 3).
DISCUSSION
This is the first study to report on the comparative performance of 22G FG needle and 
22G RB needle in acquiring adequate tissue after blinded assessment. There was good 
correlation between the independent cytopathological review and original report. The 
location of the lesion and the use of FG needle were independent predictors of 
improved tissue adequacy; however, the latter was the only modifiable variable in this 
study that could improve tissue acquisition.
The superior performance of FG needle is likely due to its three plane (Franseen 
geometry) cutting tip which may have enhanced tissue acquisition. A prospective 
study comparing FG needle and FNA needle reported that the FG needle performed 
significantly better compared to FNA needle for median area of total tissue and cell 
block diagnostic yield[47]. However, the study did not report an independent 
association between FG needle and improved sample adequacy.
Lesion location was also independently associated with improved sample adequacy. 
This finding is in line with a retrospective study analysing EUS-guided Trucut biopsy 
from 247 patients which reported that the site of biopsy was an independent predictor 
of diagnostic yield[3].
In addition to Euro-cytology classification, we also assessed the number of cell 
clusters as an indirect marker of tissue acquisition. Larger lesions and the use of FG 
FNB needle were significantly associated with ≥ 50 cell clusters in the specimens. 
Bethesda system of classification for thyroid nodule FNA specimens suggests that 
there should be at least 6 cell clusters with each cluster having at least 10 
representative cells for the sample to be deemed adequate[48]. However, no such 
requirement exists for GI and pancreatic lesions to assess sample adequacy. Based on 
cytopathologist review, 50 or more cell clusters with at least two cells in each cluster 
was chosen as the most reliable alternate indicator of tissue adequacy. We speculate 
that 50 or more cell clusters with at least 2 cells in each cluster would enable the 
cytopathologist to make a diagnosis with high confidence in distinguishing benign 
from malignant lesions. This, however, needs further evaluation and validation in 
future studies.
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Table 1 Baseline characteristics of patients included in this study (n = 226)
22G RB needle (n = 128) 22G FG needle (n = 98)
Baseline characteristic
n (%) or (mean ± SD) n (%) or (mean ± SD)
P value
Location of lesion
Gut wall lesions1 17 (13) 13 (13.3)
Pancreatic lesions 65 (51) 58 (59.2)
Lymph node 23 (18) 15 (15.3)
Extramural lesions2 23 (18) 12 (12.2)
0.55
Lesion nature
Solid 124 (97) 92 (94)
Mixed 4 (3) 6 (6)
0.34
Lesion size (mm) 35.0 (20.9) 36.0 (16.0) 0.67
Age (year) 66.3 (12.4) 68.1 (11.6) 0.29
Gender
Female 58 (45) 39 (40)
Male 70 (55) 59 (60)
0.42
Presence of trainee
Yes 39 (30) 40 (41)
No 89 (70) 58 (59)
0.12
Number of passes 3.1 (0.8) 3.2 (0.7) 0.77
Contrast sonovue
Yes 1 (1) 4 (4)
No 127 (99) 94 (96)
0.17
1Gut wall lesions include oesophageal, gastric, duodenal or rectal wall lesions. 
2Extramural lesions-does not include pancreatic lesions and lymph node. RB: Reverse bevel; FG: Franseen geometry.
The independent association between lesion size and higher number of cell clusters 
corroborates previous study findings. A retrospective study on 583 patients reported a 
strong correlation between diagnostic yield and the size of the lesion[5]. Another 
retrospective study involving 271 patients reported that the size of the lesion was an 
independent factor for tissue acquisition[8]. These indicate that care is needed with 
smaller lesions and the type of needle used, a modifiable factor, become even more 
important in smaller lesions.
Three passes is being considered sufficient when using 22G for tissue acquisition. 
Three or more number of passes with FNA needle has been shown to have a 
satisfactory sensitivity, specificity, positive predictive value, negative predictive value 
and accuracy of 84.3%, 97%, 99%, 64%, and 84%, respectively[21]. Given that the FNB 
needle requires significantly lower passes for adequate tissue acquisition[18], it is not 
unreasonable to speculate that the number of passes made in this study was more than 
adequate for tissue acquisition in both needle groups (mean > 3 in both FG and RB 
needle groups), and therefore could be the reason why it was not an independent 
predictor of adequate tissue acquisition. This is further supported by a previous 
retrospective study which showed adequate yield of histological material with lower 
number of passes[45].
A randomized control trial (RCT) comparing FG needle and fork tip needle reported 
a diagnostic cell block yield of 92% and 96%, respectively with no statistical 
significance between the two needles[49]. Another RCT comparing FG and FNA needles 
reported a diagnostic cell block yield of 97.8% for FG needle[42]. An observational study 
comparing 20G forward bevel needle and 22G FG needle found no difference in 
histological diagnosis rate, but FG needle achieved longer mean cumulative length of 
tissue core biopsies per needle pass[50]. A prospective study comparing FG needle with 
standard FNA (expect, Boston scientific) needle reported increased rate of tissue 
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Table 2 Factors associated with tissue adequacy-univariable and multivariable logistic regression analysis
Univariable analysis Multivariable analysis
Insufficient tissue (C1) (n = 
29)
Sufficient tissue (C2-C5) (n = 
197)Factors
n (%) or (mean ± SD) n (%) or (mean ± SD)
P value OR (95%CI) P value
FNB needle useda
22G RB needle 22 (76) 106 (59)
22G FG needle 7 (24) 91 (41)
0.03 3.01 (1.15-7.86) 0.02
Gender
Female 12 (41) 85 (43)
Male 17 (59) 112 (57)
1.00
Age (years) 66.7 (16.4) 67.2 (11.4) 0.88
Presence of trainee
Yes 7 (24) 72 (37)
No 22 (76) 125 (63)
0.22
Location of lesiona
Gut wall lesions1 6 (20) 24 (12) 2.64 (0.85-8.19) 0.09
Pancreatic lesions 8 (28) 115 (58) 9.42 (3.51–25.33) < 0.01
Lymph node 15 (52) 23 (12)
< 0.01
1.18 (0.00–669.44) 0.99
Extramural lesions2 0 (0) 35 (18) 1.00
Lesion size (mm) 30.1 (20.4) 36.2 (18.6) 0.11
Lesion nature
Solid 27 (94) 189 (96)
Mixed 2 (6) 8 (4)
0.62
Number of passes made 3.1 (0.7) 3.1 (0.8) 0.61
Sonovue contrast
Yes 1 (97) 4 (2)
No 28 (3) 193 (98)
0.50
aParameters with a P < 0.10 on univariable analysis were included in the multivariable analysis and these parameters are indicated by an asterisk. 
1Gut wall lesions include oesophageal, gastric, duodenal or rectal wall lesions. 
2Extramural lesions do not include pancreatic lesions and lymph node. Tissue adequacy: C1: Insufficient; C2: Benign; C3: Atypical; C4: Suspicious; C5: 
Malignant. FNB: Fine needle biopsy; RB: Reverse bevel; FG: Franseen geometry.
acquisition with FG needle[43]. In par with previous literature, the cytological yield of 
FG needle in our study was 93%. Such high tissue yield with newer needles is likely 
ameliorate the need for ROSE in the future.
A major limitation of this study is its retrospective nature and the potential for 
inherent selection bias. It was difficult to ascertain if a particular needle was chosen 
due to stock availability, personal preference, or due to lesion characteristics. 
However, given that the baseline characteristics were similar between the two needle 
groups, it is less likely that the above mentioned factors would have impacted the 
study significantly. Further, the blinding of cytopathologist to the needle used and the 
original report is likely to mitigate the bias and improve the reproducibility of this 
study.
In conclusion, tissue adequacy of 22G FG FNB needle was superior to 22G RB FNB. 
Further, the type of needle seems to be the only modifiable factors that impacts 
adequate tissue acquisition. Multicentre prospective trials are needed to further 
evaluate the utility of different needle types.
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Table 3 Factors associated with number of cell groups-univariable and multivariable logistic regression analysis
Univariable analysis Multivariable analysis
< 50 cell clusters (n = 138) ≥ 50 cell clusters (n = 88)
Factors
n (%) or (mean ± SD) n (%) or (mean ± SD)
P value OR (95%CI) P value
FNB needle useda
22G RB needle 85 (62) 43 (49)
22G FG needle 53 (38) 45 (51)
0.07 1.79 (1.02 - 3.12) 0.04
Gender
Female 65 (47) 32 (36)
Male 73 (53) 56 (64)
0.13
Age (yr) 66.8 (12.3) 67.5 (11.7) 0.67
Presence of trainee
Yes 44 (32) 35 (40)
No 94 (68) 53 (60)
0.25
Location of lesion
Gut wall lesions1 20 (14) 10 (11)
Pancreatic lesions 78 (57) 45 (51)
Lymph node 23 (17) 15 (17)
Extramural lesions2 17 (12) 18 (21)
0.39
Lesion size (mm)a 33.1 (16.9) 39.0 (21.2) 0.02 1.02 (1.00 – 1.03) 0.02
Lesion naturea
Solid 129 (93) 87 (99)
Mixed 9 (7) 1 (1)
0.09 0.13 (0.02 - 1.10) 0.06
Number of passes made 3.1 (0.8) 3.2 (0.8) 0.65
Sonovue contrast
Yes 3 (2) 2 (2)
No 135 (98) 86 (98)
1.00
aParameters with a P < 0.10 on univariable analysis were included in the multivariable analysis and these parameters are indicated by an asterisk. 
1Gut wall lesions include oesophageal, gastric, duodenal or rectal wall lesions. 
2Extramural lesions do not include pancreatic lesions and lymph node. FNB: Fine needle biopsy; RB: Reverse bevel; FG: Franseen geometry.
ARTICLE HIGHLIGHTS
Research background
Many factors can affect endoscopic ultrasound fine needle biopsy (EUS-FNB) 
procedures tissue acquisition efficacy, with needle type and design being one of the 
possible factors.
Research motivation
Currently, there is no direct comparison of tissue acquisition efficacy between reverse 
bevel (RB) and Franseen geometry (FG) needles.
Research objectives
To look any for different in tissue acquisition performance between RB and FG 
needles, which can potentially be a modifiable factor to improve EUS-FNB accuracy in 
making a confident diagnosis.
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Research methods
A retrospective study of all EUS-FNA/FNB procedures by either 22G RB needle or 
22G FG needle between January 2016 and February 2019. All cytology slides were 
reviewed by an independent gastrointestinal cytopathologist blinded to the needle 
used and the initial cytology report. The primary and secondary outcomes were to 
assess the sample adequacy using Euro-cytology criteria and the number of cell 
clusters, respectively.
Research results
A total of 226 procedures were included. RB needle was used in 128 procedures and 
FG needle in 98 procedures. The baseline characteristics of both groups were 
comparable. On multivariable analysis, FG needle (P = 0.02) and location of the lesion (
P < 0.01) were independently associated with adequate. Further, the use of FG needle (
P = 0.04) and the size of the lesion (P = 0.02) were independently associated with 
acquisition of increased number of cell clusters.
Research conclusions
FG needle is superior to RB needle in acquiring adequate tissue and attaining higher 
number of cell clusters for solid and mixed lesions.
Research perspectives
Multicentre prospective trials are needed to further evaluate the utility of different 
needle types.
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